Last updated on June 2019
A Study of Azacitidine in Myelodysplastic Syndrome (MDS) Associated to Systemic Auto-immune and Inflammatory Disorders
Brief description of study
This study is a phase II of effcicacy and tolerance of azacitidine in patients with myelodysplatic syndrome and steroid dependent or resistent systemic auto-immune and inflammatory disorders
Detailed Study Description
This trial will be a prospective French nationwide study analyzing the effect of treatment with azacitidine in patients with MDS-associated SAID with steroid dependence and/or resistance, and its correlation with possible changes in immunological parameters
Clinical Study Identifier: NCT02985190
Start Over
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
